首页 | 本学科首页   官方微博 | 高级检索  
检索        

Array-CGH筛选的FOXM1在乳腺导管内癌的表达和预后价值
引用本文:王永南,张安秦,李文萍,何舟,李辉斌.Array-CGH筛选的FOXM1在乳腺导管内癌的表达和预后价值[J].广东医学,2017,38(11).
作者姓名:王永南  张安秦  李文萍  何舟  李辉斌
作者单位:1. 广东省妇幼保健院乳腺疾病防治中心 广东广州511400;2. 广东省妇幼保健院病理科 广东广州511400
基金项目:广东省医学科研基金立项课题
摘    要:目的 探讨基于微阵列比较基因组杂交技术(Array-CGH)筛查的FOXM1对乳腺导管内癌(DCIS)预后的预测价值.方法 收集DCIS和乳腺浸润性导管癌的石蜡标本共101例,通过免疫组化检测基于Array-CGH筛查的FOXM1的表达情况,评估FOXM1对预测导管内癌预后的作用.结果 免疫组化检测到FOXM1在DCIS的阳性率为59.4% (60/101),其表达在单纯DCIS低于伴有微浸润的DCIS(DCIS-MI)(12.2% vs 31.7%,P =0.032),但与年龄、绝经状态、肿瘤大小、腋窝淋巴结状态、激素受体状态、HER2状态无明显关系.中位随访62个月,全组患者无病生存率为97.0%,总生存率为100%,FOXM1阴性组和FOXM1阳性组的无病生存率差异无统计学意义(97.6% vs 96.7%,P=0.787).单纯DCIS与DCIS-MI的无病生存率差异无统计学意义(98.7%vs94.7%,P=0.257).FOXM1阳性组,单纯DCIS与DCIS-MI的无病生存率差异无统计学意义(97.6%vs 94.4%,P =0.523);但FOXM1阴性组,单纯DCIS的无病生存率优于DCIS-MI的无病生存率(100.0%vs 85.7%,P=0.028).结论 FOXM1的阳性表达率在DCIS-MI高于单纯DCIS,其可能在DCIS发生浸润过程中起作用.FOXM1阴性表达,可能预测DCIS-MI的预后比单纯DCIS差.

关 键 词:乳腺导管内癌  FOXM1蛋白质  预后

The expression and prognostic value of FOXM1 screened by Array-CGH in ductal carcinoma in situ of breast
WANG Yong-nan,ZHANG An-qin,LI Wen-ping,HE Zhou,LI Hui-bin.The expression and prognostic value of FOXM1 screened by Array-CGH in ductal carcinoma in situ of breast[J].Guangdong Medical Journal,2017,38(11).
Authors:WANG Yong-nan  ZHANG An-qin  LI Wen-ping  HE Zhou  LI Hui-bin
Abstract:Objective To investigate the expression and the predictive prognosis value of FOXM1 screened by Array-CGH (array-comparative genomic hybridization,Array-CGH) in ductal carcinoma in situ of breast.Methods A total of 101 paraffin specimens of breast ductal carcinoma and breast invasive ductal carcinoma were collected from January 2007 lo December 2014.The expression of FOXM1 screened by Array-CGH was detected by immunohistochemistry,and the prognosis of breast ductal carcinoma was evaluated.Results The positive rate of FOXM1 protein in breast ductal carcinoma was 59.4% (60/101),with no significant correlation with age,menopause,tumor size,axillary lymph node status,HR status,or HER-2 status.FOXM1 expression in pure DCIS was significantly lower than ductal carcinoma in situ with microinvasiveness (12.2% vs.31.7%,P =0.032).The median follow-up was 62 months.Disease-free survival rate of all was 97.0%.There was no significant difference in disease-free survival between FOXM1 negative group and FOXM1-positive group (97.6% vs.96.7%,P =0.787).Overall survivals were both 100% in FOXM1 negative and positive groups.There was no significant difference between pure DCIS and DCIS-MI in DFS (98.7% vs.94.7%,P =0.257).There was no significant difference in DFS between pure DCIS patients and DCIS-MI patients in FOXM1 positive group (97.6% vs.94.4%,P =0.523).In FOXM1 negative group,DFS in pure DCIS patients was significantly superior to DCIS-MI patients (100% vs.85.7%,P =0.028).Conclusion The positive expression of FOXM1 in DCIS-MI is higher than pure DCIS,which may play a role in the infiltration process of DCIS.The negative expression of FOXM1 may predict the poorer prognosis of DCIS-MI than the pure DCIS.
Keywords:Ductal carcinoma in situ  FOXM1 protein  Prognosis
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号